Artificial Intelligence (AI) in Pharmaceuticals: Global Markets

Report Code: AIT020A

Publish Date: Sep 2025

Publisher: BCC Publishing

Category: AI Technology

Download Report Overview

CUSTOMIZE NOW

Explore Our Services

Already a member? Login to access this report free.

Report Highlights

The global market for artificial intelligence (AI) in pharmaceuticals is estimated to grow from $3.8 billion in 2025 to reach $15.2 billion by the end of 2030, at a compound annual growth rate (CAGR) of 31.7% from 2025 through 2030.

Report Includes

  • 27 data tables and 62 additional tables
  • An analysis of the global markets for artificial intelligence (AI) in the pharmaceuticals industry
  • Analyses of the global market trends, with historic revenue (sales figures) from 2022 to 2024, estimates for 2025, and projections of CAGRs through 2030
  • Estimates of the market’s size and revenue growth prospects, accompanied by a market share analysis by product type, application and region
  • Facts and figures pertaining to market dynamics, technological advances, regulations, prospects and the impacts of macroeconomic variables
  • Insights derived from Porter’s Five Forces model, as well as a global supply chain analysis
  • Case studies on AI implementation to streamline processes across drug discovery and development, manufacturing, quality control and patient care
  • A relevant patent analysis, featuring key granted and published patents
  • Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, as well as the ESG risk ratings and practices of leading companies
  • Analysis of the industry structure, including companies’ market shares and rankings, strategic initiatives, M&A activity and a venture funding outlook
  • Profiles of the leading companies, including Google DeepMind, Atomwise Inc., Insilico Medicine, Recursion Pharmaceuticals and Nvidia Corp.

Report Scope

This report on the global market for AI in pharmaceuticals explores market dynamics and trends, and analyzes technological developments, software performance, clinical trials, new product approvals and emerging technologies. The report also includes profiles of leading companies and their strategies.

The report explores how AI is transforming the pharmaceutical industry through enhanced diagnostic capabilities, early disease detection, clinical trial optimization, drug discovery and personalized treatment planning. It also examines AI disruption across industry verticals and value chain stages, while presenting market spending patterns, investment forecasts, R&D expenditures and venture capital funding. The report segments the market by product type, application and region. Types include software and services. Applications include drug discovery and development, clinical trials, personalized medicines and others. The four regions covered are North America, Europe, Asia-Pacific and the Rest of the World. For market estimates, data has been provided for 2024 as the base year, with forecasts for 2025 through 2030.

Report Synopsis

Report Metrics Details
Base year considered 2024
Forecast period considered 2025-2030
Base year market size $3.0 Billion
Market size forecast $15.2 Billion
Growth rate CAGR of 31.7% from 2025 to 2030
Units considered $ Millions
Segments covered Product Type, Application and Region
Regions covered North America, Europe, Asia-Pacific, and the Rest of the World (RoW)
Key Market Drivers
  • Increasing adoption of AI in clinical trials.
  • Faster drug discovery and development.
  • Demand for precision medicine and AI applications.
Companies studied
AICUREATOMWISE INC.
BENEVOLENTAIGOOGLE DEEPMIND
HEALXIKTOS
INSILICO MEDICINEINVENIAI LLC.
NVIDIA CORP.PATHAI INC.
RECURSIONSCHRODINGER INC.
SYRENCLOUD INC.TEMPUS AI INC.
XTALPI INC.
Need pricing for multiple titles, a complete report bundle, or something specially curated to fit your budget? EXPLORE OFFERS

Frequently Asked Questions (FAQs)

The global market for artificial intelligence (AI) in pharmaceuticals was valued at $3 billion in 2024 and is expected to reach $15.2 billion by the end of 2030 at a CAGR of 31.7%.
Key factors driving the AI in the pharmaceutical market include:

  • Increasing adoption of AI in clinical trials;
  • Faster drug discovery and development;
  • Demand for precision medicine and AI applications.
Key challenges include data challenges and regulatory & ethical concerns.
The market is segmented based on product type, application and region. The market is segmented into software and services based on equipment type. Based on the application, the market is segmented into drug discovery and development, clinical trials, personalized medicines and others. The market has been segmented by geographical region into North America, Europe, Asia-Pacific, and the Rest of the World (RoW). The North American region includes the U.S., Canada and Mexico. Europe includes Germany, the U.K., Italy, France, Spain, and the Rest of Europe; Asia-Pacific includes China, Japan, India, and the Rest of Asia-Pacific. The rest of the World (RoW) includes South America, the Middle East and Africa. It includes global revenue ($ Million) for the base year 2024 and estimated data for the forecast period 2025 through 2030.
Software segment will dominate the AI in the pharmaceutical market.
North America accounted for 59.5% share of the market in 2024.

Analyst Credentials

BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.

Let us assist you! Our analysts are ready to tailor this report to your specific need. Talk to Our Analyst

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesMember Price
Full Report: Artificial Intelligence (AI) in Pharmaceuticals: Global Markets139Free
Chapter- 1: Executive Summary6Free
Chapter- 2: Market Overview8Free
Chapter- 3: Market Dynamics8Free
Chapter- 4: Regulatory Landscape4Free
Chapter- 5: Emerging Trends and Pipeline Analysis13Free
Chapter- 6: Market Segment Analysis44Free
Chapter- 7: Competitive Intelligence10Free
Chapter- 8: Sustainability in AI in the Pharmaceutical Industry: ESG Perspective3Free
Chapter- 9: Appendix43Free

Related Reports

AI Adoption: A Global Perspective

Published - Jan 2026 | Publisher - BCC Publishing | Code - AIT001C

This report provides an in-depth analysis of artificial intelligence (AI) adoption across various industries. It includes current state of AI, regulations and standards, and key barriers to this technology adoption. The report focuses on AI adoption in hardware, software and service solutions, including company evaluations for each solution. It also presents application-specific case studies for successful implementation of AI across the major industry verticals. The report concludes with future perspectives of AI adoption in key sectors over the coming years.

AI Use Case Analysis: Global Outlook

Published - Jan 2026 | Publisher - Austin Samuel | Code - AIT002C

This report provides a comprehensive analysis of artificial intelligence (AI) use cases across technologies, industries, and organizational contexts. The study presents detailed qualitative insights, focusing on how AI applications are evolving, scaling, and creating business value. The scope covers AI use cases across key technology domains, major industry verticals, and startup ecosystems, offering structured visibility into adoption patterns, maturity levels, and real-world implementation scenarios.

AI in Biotechnology: Global Markets

Published - Aug 2025 | Publisher - BCC Publishing | Code - AIT016A

The global market for AI in biotechnology was valued at $3.8 billion in 2024. The market is estimated to grow from $4.6 billion in 2025 to $11.4 billion by 2030, at a compound annual growth rate (CAGR) of 20% from 2025 to 2030.

Global Pharmaceutical Drugs Industry: Competitive Landscape 2023

Published - May 2025 | Publisher - BCC Publishing | Code - PHM263B

This report discusses the global pharmaceutical drugs industry and its competitive landscape in terms of significant player market ranking and top pharmaceutical drugs. Company profiles of the top 50 pharmaceutical companies, innovative products and technologies, trends and market dynamics, competitive intelligence, and regional trends are well-researched and analyzed in this report.

Track the Latest Global Tariff Developments

In today's fast-paced global economy, tariffs are no longer static—they are dynamic levers shaped by geopolitical realignments, supply chain vulnerabilities, inflationary pressures, and sustainability-driven trade reforms. As governments worldwide recalibrate their trade strategies, businesses are left to navigate a maze of shifting rules, rising costs, and regulatory uncertainty.

Our analysis empowers you with real-time updates and in-depth expert analysis on all facets of global tariff activity. From new trade agreements and sanctions to abrupt tariff hikes and retaliatory duties, we monitor developments across borders, sectors, and industries—so you don't have to.

Whether it's the ongoing U.S.–China trade dynamics, the evolving EU Carbon Border Adjustment Mechanism (CBAM), or the emerging policies in India, ASEAN, and Latin America, we provide full-spectrum coverage. We also track multilateral trade negotiations, World Trade Organization (WTO) rulings, and sector-specific duty structures—ensuring you are always ahead of global trade shifts.

With our analysis, you can stay informed, identify risks, and confidently respond to tariff changes—no matter where you operate.

Ready to see what tariff means for your business?

Consult with our experts or request your custom Tariff Impact Brife today

Stay Informed, Stay Competitive

In today's interconnected and unpredictable global economy, staying ahead of tariff shifts is not just important—it's essential. BCC Research provides decision-makers with trusted, research-driven insights that turn uncertainty into opportunity.

Our in-depth market analysis and trade intelligence help you decode how tariff changes impact your specific sector—manufacturing, healthcare, technology, agriculture, or energy. We break down complex data into actionable knowledge through comprehensive reports, expert commentaries, and sector-focused forecasts.

Our analysis includes:

  • Thorough breakdowns of current and proposed tariff policies and how they affect regional and global trade flows.
  • Sector-specific implications, helping you understand the strategic impact on sourcing, pricing, and competitiveness.
  • Forward-looking insights to support risk management, planning, and response strategies for evolving trade conditions.

With BCC Research, you gain more than just information—you gain clarity and confidence to make well-informed decisions in a volatile trade environment.

Don't let tariffs catch you off guard—let our insights guide your strategy.

This is an Excel-only version of the report.

Report Includes

    Total Number of Tables in this Report: 89

  • Summary Table: Global Market for AI in Pharmaceuticals, by Region, Through 2030
  • Table 1: Collaborations Between AI Software and Pharmaceutical Companies
  • Table 2: FDA AI/ML Initiatives and Milestones, 2014 and 2025
  • Table 3: EMA AI/ML Regulatory Development Timeline, 2021–2024
  • Table 4: Clinical Trial Data for AI in Pharmaceutical Drugs, 2025
  • Table 5: Granted Patents for AI in Pharmaceuticals, 2022–2025
  • Table 6: Global Market for AI in Pharmaceuticals, by Product Type, Through 2030
  • Table 7: Global Market for AI Software in Pharmaceuticals, by Region, Through 2030
  • Table 8: Global Market for Services in AI in Pharmaceuticals, by Region, Through 2030
  • Table 9: Global Market for AI in Pharmaceuticals, by Application, Through 2030
  • Table 10: AI Tools Used in Drug Discovery
Sample Report

Recent Reports

AI Use Case Analysis: Global Outlook

Published - Jan 2026 | Publisher - BCC Publishing | Code - AIT002C

This report provides a comprehensive analysis of artificial intelligence (AI) use cases across technologies, industries, and organizational contexts. The study presents detailed qualitative insights, focusing on how AI applications are evolving, scaling, and creating business value. The scope covers AI use cases across key technology domains, major industry verticals, and startup ecosystems, offering structured visibility into adoption patterns, maturity levels, and real-world implementation scenarios.

Global AI Investment Trends & Spending Outlook

Published - Jan 2026 | Publisher - BCC Publishing | Code - AIT004C

The report analyzes global AI investment growth, focusing on corporate and private funding, mergers and acquisitions, and venture capital trends. It also compares regional VC investment patterns worldwide.

AI Adoption: A Global Perspective

Published - Jan 2026 | Publisher - BCC Publishing | Code - AIT001C

This report provides an in-depth analysis of artificial intelligence (AI) adoption across various industries. It includes current state of AI, regulations and standards, and key barriers to this technology adoption. The report focuses on AI adoption in hardware, software and service solutions, including company evaluations for each solution. It also presents application-specific case studies for successful implementation of AI across the major industry verticals. The report concludes with future perspectives of AI adoption in key sectors over the coming years.

AI Disruption: A Global Overview

Published - Jan 2026 | Publisher - BCC Publishing | Code - AIT003C

This report provides an up-to-date analysis of current and future AI disruptions across major industries and global regions. It highlights AI disruptions in multiple industries; explains the innovations behind development; and integrates case studies, governmental data and platform-specific AI developments to deliver a holistic and strategic perspective on global AI disruptions.

AI Impact on Commercial Refrigeration Equipment Market - BCC Pulse Report

Published - Jan 2026 | Publisher - BCC Publishing | Code - AIT105A

This report provides a brief study of AI impact on the market for commercial refrigeration equipment. It highlights major adoption trends across the key geographic regions, and disruptions caused across several key industry verticals.

Top Trending Reports

Genetic Modification Therapies Clinical Applications: Gene Therapies, Genetically Modified Cell Therapies, RNA Therapies and Gene Editing

Published - Dec 2025 | Publisher - BCC Publishing | Code - BIO159B

The global market for genetic modification therapies is estimated to grow from $14.8 billion in 2025 to reach $32.1 billion by the end of 2030, at a compound annual growth rate (CAGR) of 16.8% from 2025 through 2030.

Global Markets for Diabetes Therapeutics and Diagnostics

Published - Jan 2026 | Publisher - BCC Publishing | Code - HLC029G

The global market for diabetes therapeutics and diagnostics is estimated to grow from $134.9 billion in 2025 to reach $241.5 billion by the end of 2030, at a compound annual growth rate (CAGR) of 12.4% from 2025 through 2030.

Carbon Fiber: Global Markets

Published - Dec 2025 | Publisher - BCC Publishing | Code - AVM206B

The global market for carbon fiber was valued at $4.9 billion in 2024 and is estimated to increase from $5.3 billion in 2025 to reach $8.2 billion by 2030, at a compound annual growth rate (CAGR) of 9.1% from 2025 through 2030.

Global Oncology Biosimilars Market

Published - Dec 2025 | Publisher - BCC Publishing | Code - PHM286A

The global market for oncology biosimilars is estimated to grow from $9.6 billion in 2025 and projected to reach $17.5 billion by the end of 2030, at a compound annual growth rate (CAGR) of 12.6% from 2025 to 2030.

Sleep Aids: Technologies and Global Markets

Published - Jan 2026 | Publisher - BCC Publishing | Code - HLC081F

The global market for sleep aid technologies is estimated to grow from $103.5 billion in 2025 to reach $136 billion by 2030, at a compound annual growth rate (CAGR) of 5.6% from 2025 to 2030.

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More
Artificial Intelligence (AI) in Pharmaceuticals: Global Markets
Sample Report
AI Sentiment